Cargando…
Reply to “Survival analysis in a prediction model for early systemic recurrence in breast cancer”
Autores principales: | Osako, Tomo, Matsuura, Masaaki, Tsuda, Hitoshi, Noguchi, Shinzaburo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286758/ https://www.ncbi.nlm.nih.gov/pubmed/35969034 http://dx.doi.org/10.1002/cncr.34415 |
Ejemplares similares
-
A prediction model for early systemic recurrence in breast cancer using a molecular diagnostic analysis of sentinel lymph nodes: A large‐scale, multicenter cohort study
por: Osako, Tomo, et al.
Publicado: (2022) -
Validation of the prognosis of patients with ER‑positive, HER2‑negative and node‑negative invasive breast cancer classified as low risk by Curebest(™) 95GC Breast in a multi‑institutional registry study
por: Naoi, Yasuto, et al.
Publicado: (2023) -
Reply : Understanding survival comparisons in non-randomized treatment comparisons for patients with early-stage HCC
por: Moon, Andrew M., et al.
Publicado: (2023) -
Reply to ‘Comment on ‘Anthropometric measurements and survival after prostate cancer diagnosis”
por: Farris, Megan S., et al.
Publicado: (2018) -
Reply to “Propofol and survival: an updated meta‑analysis of randomized clinical trials”
por: Gutierrez, Manuel Alberto Guerrero, et al.
Publicado: (2023)